Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Mar 27;4(3):e82.
doi: 10.1371/journal.pmed.0040082.

Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia

Zaheer Ud Din Babar  1 , Mohamed Izham Mohamed Ibrahim, Harpal Singh, Nadeem Irfan Bukahri, Andrew Creese
Affiliations

Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia

Zaheer Ud Din Babar et al. PLoS Med. .

Abstract

Background: Malaysia's stable health care system is facing challenges with increasing medicine costs. To investigate these issues a survey was carried out to evaluate medicine prices, availability, affordability, and the structure of price components.

Methods and findings: The methodology developed by the World Health Organization (WHO) and Health Action International (HAI) was used. Price and availability data for 48 medicines was collected from 20 public sector facilities, 32 private sector retail pharmacies and 20 dispensing doctors in four geographical regions of West Malaysia. Medicine prices were compared with international reference prices (IRPs) to obtain a median price ratio. The daily wage of the lowest paid unskilled government worker was used to gauge the affordability of medicines. Price component data were collected throughout the supply chain, and markups, taxes, and other distribution costs were identified. In private pharmacies, innovator brand (IB) prices were 16 times higher than the IRPs, while generics were 6.6 times higher. In dispensing doctor clinics, the figures were 15 times higher for innovator brands and 7.5 for generics. Dispensing doctors applied high markups of 50%-76% for IBs, and up to 316% for generics. Retail pharmacy markups were also high-25%-38% and 100%-140% for IBs and generics, respectively. In the public sector, where medicines are free, availability was low even for medicines on the National Essential Drugs List. For a month's treatment for peptic ulcer disease and hypertension people have to pay about a week's wages in the private sector.

Conclusions: The free market by definition does not control medicine prices, necessitating price monitoring and control mechanisms. Markups for generic products are greater than for IBs. Reducing the base price without controlling markups may increase profits for retailers and dispensing doctors without reducing the price paid by end users. To increase access and affordability, promotion of generic medicines and improved availability of medicines in the public sector are required.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Regional Variation in Median MPRs in Private Retail Sector Pharmacies
Figure 2
Figure 2. Affordability of Standard Treatments in the Dispensing Doctors' Sector and Private Sector Retail Pharmacies
See this image and copyright information in PMC

Comment in

References

    1. World Health Organization, Health Action International. Medicine prices—A new approach to measurement. Geneva: World Health Organization; 2003. Available at: http://whqlibdoc.who.int/hq/2003/WHO_EDM_PAR_2003.2.pdf. Accessed: 15 February 2007.
    1. Quick JD, Rankin JR, Laing RO, O'Connor RW, Hogerzeil HV, et al., editors. Managing drug supply. 2nd Ed. West Hartford (Connecticut): Kumarian Press; 1997. pp. 7–9.
    1. Shepard SD, Savedoff W, Hong PK. Healthcare reform initiatives in Malaysia. Report of a consultation with the planning and development division, Ministry of Health, Kuala Lumpur, Malaysia October 16. 2002. Available at: http://www.who.int/health_financing/countries/en/malaysia.pdf. Accessed: 20 February 2007.
    1. Netto A. Doctors buck privatisation of healthcare. Asia Times. 1999. Jun 19), Available at: http://www.atimes.com/se-asia/AF19Ae01.html. Accessed: 19 December 2006.
    1. Cruez AF. The income will decide the amount you pay. The Star (Malaysia) (2004. Dec 20), Available at: http://202.144.202.76/new_mps/cfm/localnews_view.cfm?id=722. Accessed 15 February 2007.

Publication types

Substances